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Recently, increasingly complex metabolic pathways have been engineered by modifying natural 13 
pathways and establishing de novo pathways with enzymes taken from a variety of organisms.  Here, we 14 
have applied retro-biosynthetic screening to a modular pathway design in order to identify a redox 15 
neutral, theoretically high yielding route to a branched C6 alcohol.  Enzymes capable of converting 16 
natural E. coli metabolites into 4-methyl-pentanol via CoA-dependent chemistry were taken from 9 17 
different organisms to form a ten step de novo pathway.  Selectivity for 4-methyl-pentanol was 18 
enhanced through the use of key enzymes acting on acyl-CoA intermediates, a carboxylic acid reductase 19 
from Nocardia iowensis, and an alcohol dehydrogenase from Leifsonia sp. Strain S749.  One 20 
implementation of the full pathway from glucose demonstrated selective carbon chain extension and 21 
acid reduction with 4-methyl-pentanol constituting 81% (90 ± 7 mg/L) of the observed alcohol products.  22 




Increasing interest in sustainable production of a wide range of chemical products has encouraged 25 
development of microbial catalysts for the conversion of renewable feedstocks to specialty and bulk 26 
chemicals as well as transportation fuels.  While natural hosts and metabolic pathways have been used 27 
for decades in the production of chemical products, the desire to synthesize direct replacements for 28 
current petroleum products has led to appropriation of natural pathways for production of noncognate 29 
chemicals 1, 2, 3.  Early examples of this new paradigm have focused on introducing or combining portions 30 
of natural pathways in alternative host organisms or creating new products by altering the termination 31 
of natural pathways of a host organism with promiscuous enzymes 1, 3, 4, 5, 6, 7, 8, 9, 10, 11.  Recent work has 32 
been focused on improving modified natural pathways by substituting new enzymes to improve kinetics, 33 
improve expression, or utilize alternate cofactors 12, 13, 14. In some cases, pathways have been 34 
repurposed to synthesize new products by capitalizing on the natural capacity of enzymes to accept 35 
closely related substrates or by engineering protein specificity 15, 16, 17.  The boldest designs have utilized 36 
previously undescribed pathways created by combining the natural chemistry of individual enzymes 37 
from multiple hosts 18, 19, 20.   38 
Liquid transportation fuels are one class of chemical targets for which natural pathways to exact 39 
replacements have not been discovered.  Recent interest in microbial production of renewable fuels has 40 
led to successful synthesis of a variety of next-generation biofuels with improved properties over 41 
ethanol 12, 14, 15, 21, 22, 23, 24, 25, 26, 27.  Microbial synthesis of these reduced chemical species by de novo 42 
designed pathways can potentially lead to more efficient production strains which are necessary for 43 
next-generation targets to achieve commercial relevance.  Predominantly these pathways have 44 
employed reconstitution of natural pathways in new hosts (acetone-butanol-ethanol (ABE)5, 6, 28) or 45 
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modified termination of natural pathways (fatty acid synthesis (FAS)11, 23, 24, amino acid synthesis12, 29, 46 
isoprenoid synthesis22).   47 
While natural metabolites of lipid and terpene synthesis closely resemble biodiesel, there are few 48 
natural metabolites that closely mimic gasoline.  Because gasoline constitutes 40% of total U.S. 49 
petroleum consumption, a bio-based gasoline alternative would be useful for alleviating petroleum 50 
reliance. Two synergistic approaches are required for making a bio-based gasoline more economical: 51 
utilization of less expensive feedstocks and implementation of high efficiency pathways 30, 31, 32, 33.  The 52 
presented work focuses on development of a high efficiency pathway for a bio-alternative alcohol for 53 
spark ignition engines.  Such an alcohol would ideally fall in the C6-C7 range 25, 26, 34.   These medium-54 
chain length alcohols achieve energy density equal to that of petroleum derived gasoline (32 MJ/L) (Fig. 55 
S1A)35, 36, 37, 38.  Branched alcohols have the additional desired property of improved octane rating (Fig. 56 
S1B)34.  To date, the best examples of synthesizing such compounds have come from modified 57 
termination of branched amino acid synthesis or from isoprenoid synthesis 22, 29.  The amino acid based 58 
pathway utilizes carbon chain extension by engineering α-ketoacid elongation (αKAE) enzymes and an α-59 
ketoacid decarboxylase to produce a blend of alcohols (Fig. 1A).  The inefficient carbon chain extension 60 
mechanism creates a redox imbalance for medium-chain products, which limits maximum pathway 61 
efficiency39.   The isoprenoid pathway can be used to produce C5 isopentenol, but it is limited to forming 62 
carbon chain lengths in multiples of five because it uses isopentenyl diphosphate (IPP) as a C5 building 63 
block, and it is limited by the inherent redox imbalance of the pathway.   64 
Here, we present a pathway design which combines a portion of a native pathway (valine biosynthesis) 65 
with a ten step de novo pathway to produce 4-methyl-pentanol.    In order to identify specific pathway 66 
variants, we utilized a conceptual modular framework based on general natural chemistries.  67 
Biosynthetic routes to alkyl chains most commonly employ a system of precursor generation followed by 68 
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chain elongation through carbon-carbon bond forming reactions40, 41, 42.  We structured our conceptual 69 
modules to correspond to this pathway structure.  We envisioned precursor generating modules 70 
(Glycolysis and Modules 1 and 2) and carbon chain elongation modules (Module 3) coupled to alcohol 71 
terminating modules (Module 4).     72 
This approach produced a pathway with enzymes selected from nine different metabolic contexts 73 
(organsims and/or pathways) (Fig. 1B and 1C).  Four enzymes were selected to act on their presumed 74 
cognate substrates and 6 were applied to presumed noncognate substrates in the engineered pathway.  75 
The core Module 3 pathway architecture is based on synthetic CoA-dependent chemistry first 76 
understood in the ABE pathway of Clostridium acetobutylicum.  This CoA-dependent architecture has 77 
several advantages compared to the αKAE and isoprenoid pathways described above.  Biosynthetic CoA-78 
dependent pathways typically utilize acetyl-CoA building blocks and extend carbon chains through 79 
condensation reactions without release of CO2.  The potential for generation of two reducing 80 
equivalents per acetyl-CoA generated from glycolysis perfectly balances with those consumed for 81 
reduction to a primary alcohol product 15, 43.  Indeed, the presented pathway achieves redox neutrality 82 
and a maximum theoretical yield of 0.67 mol 4MP/mol glucose (0.38 g/g, 100% maximum pathway 83 
energy efficiency).  β-oxidation chemistry has been used for synthesis of several straight-chain acids and 84 
alcohols 5, 6, 16, 21, 44.  Unlike these previous demonstrations of CoA-dependent pathways, here we present 85 
the expansion of potential products to branched alcohols of medium chain length using independently 86 
selected enzymes chosen to enhance specificity for our desired intermediates.   87 
Results 88 
4MP Pathway Description.  The 4MP pathway design does not rely on the simple transfer of a single 89 
recombinant pathway; rather, it relies on a patchwork of enzymes from multiple organisms and multiple 90 
natural pathways (Fig. 1A and 1B).  Figure 1 presents the overall pathway as a composite of 4 modules.  91 
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Module 1, an adaptation of previously described routes to isobutanol and isobutyrate12, 45, converts 92 
pyruvate, from glycolysis, to α-keto-isovalerate (α-KIV) via valine biosynthesis using Bacillus subtilis 93 
acetolactate synthase AlsSBs, Escherichia coli acetohydroxy acid isomeroreductase IlvCEc, and E. coli 94 
dihydroxy acid dehydratase IlvDEc.  α-KIV is further converted to isobutyrate by the Lactococcus lactis 95 
decarboxylase KivDLl and an isobutyraldehyde preferring aldehyde dehydrogenase from Flavobacterium 96 
johnsonaie (Fjoh_2967) 46.  Module 2 consists of the ATP-dependent activator Rhodopseudomonas 97 
palustris isobutyryl-CoA ligase IbuARp which converts isobutyrate to isobutyryl-CoA 
47.  Acetyl-CoA, 98 
generated by the endogenous pyruvate decarboxylase complex, condenses with isobutyryl-CoA in the 99 
first reaction of Module 3, mediated by the Cupriavidus necator thiolase BktBCn.  The subsequent 100 
reactions of Module 3 reduce the branched 3-keto-4-methylvaleryl-CoA intermediate to 4-methyl-101 
valeryl-CoA by C. necator acetoacetyl-CoA reductase PhaBCn, C. necator enoyl-CoA hydratase PhaJ4bCn, 102 
and Treponema denticola enoyl-CoA reductase TerTd  
14, 15, 48, 49, 50, 51, 52.  Endogenous thioesterase activity 103 
(potentially from TesB and YdiI53)  generates free 4-methyl-valerate (4MV) .  Module 4 reduces the free 104 
4MV to 4MP by the Nocardia iowensis carboxylic acid reductase CarNi and either Saccharomyces 105 
cerevisiae alcohol dehydrogenase Adh6pSc or Leifsonia sp. Strain S749 alcohol dehydrogenase Lsadh 
54, 55, 106 
56, 57, 58 (see Supplementary Fig. S2 for enzyme cofactor requirments and byproduct reactions).  107 
Throughout this manuscript, strain names indicate the modules present in the strain (i.e., M1F2I34 108 
includes “M” for modules, “1F” for Module 1 with feaBEc, “2I” for Module 2 with ibuARp, “3” for Module 109 
3, and “4” for Module 4).  Strain names with “( )” contain abbreviations for operon structure indicating 110 
the order of alsSBs and ilvCEc (i.e., M1F(IA)2I34 includes (IA) indicating an ilvCEc-alsSBs operon order).  See 111 
Table 1 and Supplementary Table S1 for descriptions of all strains used and Supplementary Table S2 for 112 
relevant descriptions of enzymes used in all pathway variants. 113 
Identification of Acid and Aldehyde Reductases for Synthesis of 4MP (Module 4).  Adoption of a CoA-114 
dependent synthesis route required identification of pathways to link a saturated CoA thioester to the 115 
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final alcohol product.  The CoA thioester could be reduced by either a CoA-dependent aldehyde 116 
dehydrogenase or thioesterase/carboxylic acid reductase pairing.  The resulting aldehyde could then be 117 
reduced by an alcohol dehydrogenase to generate the primary alcohol product.  The wide array of 118 
identified alcohol dehydrogenases created a high probability that an alcohol dehydrogenase could be 119 
found for conversion to the final alcohol 13, 61, 62.  S. cerevisiae Adh6pSc was initially selected because it 120 
was previously found to be a broad specificity alcohol dehydrogenase with high activity on medium- and 121 
branched-chain aliphatic aldehydes54.   122 
A smaller number of acid or CoA-thioester reductases have been characterized in the literature.  From 123 
these previously identified enzymes, we looked to identify candidates with the potential to selectively 124 
convert 4MV to 4-methyl-valeraldehyde.  Recently, a carboxylic acid reductase (Car) from 125 
Mycobacterium marinum was shown to convert a range of straight-chain fatty acids to fatty aldehydes, 126 
but with increasing catalytic efficiency (kcat/KM) for longer chain lengths 
59.  A previously studied 127 
homolog, Car from N. iowensis, was found to have activity on a broad array of acids, but its activity on a 128 
range of aliphatic acids was not examined60.   CarNi from N. iowensis was selected for further study to 129 
determine if it had specificity for targeted medium-chain branched acids.   130 
Assays were devised to confirm activity on desired substrates in vitro and in vivo.  First, N-terminal His-131 
tagged CarNi was purified and assayed for relative activity on 13 straight and branched acid substrates 132 
from C2-C8.    CarNi showed a peak in activity for acids with a primary chain-length of 5-6 carbons (Fig. 133 
2A).  The highest CarNi activity was found for the branched species 4MV and 4-methyl-hexanoate.  Given 134 
the need to reduce flux of precursors to undesired byproduct alcohols, CarNi was a logical selection 135 
because of its preference for 4MV over the short-chain acids acetate, isobutyrate, and butyrate.  A 136 
complementary in vivo assay was designed to examine the effectiveness of the Module 4 pairing.   137 
Butyrate, valerate, 3-methyl-valerate, 4MV, and hexanoate were fed to E. coli cultures expressing 138 
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CarNi/Adh6pSc and conversion was monitored by sampling the culture media.  OD600-normalized 139 
conversions followed a trend similar to observed in vitro results with maximal conversion for substrates 140 
with C5 primary chain length, as desired (Supplementary Fig. S3).   141 
Strong specificity of CarNi for 4MV over isobutyrate was desired because isobutyrate is produced as an 142 
upstream intermediate.  The Michaelis-Menten kinetic parameters of CarNi were found using these two 143 
key intermediates to confirm the desired specificity (Fig. 2B).  The kcat/Km ratio with 4MV was found to 144 
be 450 times higher than with isobutyrate, indicating the significant preference of CarNi for 4MV over 145 
other acid substrates generated by the pathway.  With a Km of 78 ± 9 mM with isobutyrate, CarNi is 146 
expected to convert isobutyrate poorly under physiologically relevant concentrations, which limits 147 
shunting of the precursor to isobutyraldehyde.   148 
Identification of Dehydratases and Reductases for Synthesis of 4MV (Module 3).   Enzymes of the 149 
Clostridium acetobutylicum butanol pathway and enzymes from polyhydroxyalkanoate pathways have 150 
previously been used to synthesize straight chain butanol and pentanol 14, 15, 21.  Previous work from our 151 
group found the bktBCn/phaBCn combination is capable of synthesizing 3-hydroxy-4-methylvaleryl-CoA 152 
from isobutyryl-CoA and acetyl-CoA 51.   To the best of our knowledge, 3-hydroxy-acyl-CoA dehydratases 153 
and trans-enoyl reductases with activity on the subsequent branched intermediates have not been 154 
identified.  From enzymes documented to have activity on straight medium-chain CoA substrates, 4 phaJ 155 
and 6 ter homologs were selected for further screening 49, 50 (Supplementary Table S1).  An assay was 156 
developed to screen for enzymes with the desired activity by isolating Modules 2 and 3 of our pathway 157 
in vivo with different combinations of dehydratases and reductases.    Isobutyrate (10 mM) and glucose 158 
(1%) were supplied in LB medium, and active gene combinations were identified by detecting 4MV 159 
secretion.   The propionyl-CoA transferase from Megasphera elsdenii, pctMe, was used to activate 160 
isobutyrate 63.  Of the 24 combinations tested, phaJ4 homologs from Pseudomonas syringae, 161 
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Pseudomonas aeruginosa, and C. necator in combination with ter homologs from Vibrio 162 
parahaemolyticus and T. denticola produced 4MV (Supplementary Fig. S4A).  The high producer, C. 163 
necator phaJ4bCn/T. denticola terTd (Strain M3Sc-TdCn), yielded 297 ± 45 mg/L 4MV and was selected for 164 
Module 3 moving forward.  The previously used dehydratase hbdCa and reductase crtCa from the 165 
Clostridium acetobutylicum butanol pathway were also tested in place of phaBCn and phaJ4bCn (Strain 166 
M3Sc-Ca) (Supplementary Fig. S4B).  While some butyrate was produced by Strain M3Sc-Ca, 4MV was 167 
not detected.   168 
With Module 4 in vivo activity previously confirmed, 4MP production from glucose and isobutyrate was 169 
tested with a strain expressing Module 2, 3, and 4 genes (Strain M2P34).  As predicted by observed 170 
activities for CarNi and Adh6pSc, Strain M2P34 preferentially produced 4MP (272 ± 7 mg/L) over 171 
isobutanol (111 ± 7 mg/L)  and butanol (142 ± 9 mg/L) even while feeding 10 mM (870 mg/L) isobutyrate 172 
(Fig. 2C). 173 
Incorporation of a Pathway from Glucose to Isobutyryl-CoA (Modules 1 & 2).   Combining isobutyrate 174 
synthesis with CoA activation supplies the necessary isobutyryl-CoA precursor for 4MP synthesis from 175 
glucose or other simple carbon sources.  The Module 1 pathway was identified by building from the 176 
previous work of Zhang et al., which synthesized isobutyrate in E. coli by combining valine biosynthesis 177 
with the L. lactis kivDLl decarboxylase and various native aldehyde dehydrogenases, including PuuC and 178 
FeaB 45.  In previous work, our group has utilized the M. elsdenii transferase PctMe for CoA activation of 179 
carboxylic acids including isobutyrate 51. The ATP-dependent isobutyryl-CoA ligase (IbuARp) from R. 180 
palustris provides an alternative activation mechanism for Module 2 which creates a redox neutral 181 
overall pathway 47.   182 
Multiple module combinations were used to explore the activities of the two E. coli aldehyde 183 
dehydrogenases selected for the final oxidation of isobutyraldehyde to isobutyrate.  Module 1 184 
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expression with Modules 2 (pctMe) and 3, led to production of 4MV from glucose with titers up to 111 ± 185 
11 mg/L (puuCEc) and 90 ± 9 mg/L (feaBEc) (Supplementary Fig. S5A).  Module 1 with puuCEc led to higher 186 
4MV titers when coupled to Modules 2 and 3, but it was possible that the E. coli aldehyde 187 
dehydrogenases had activity on the Module 4 intermediate 4-methyl-valeraldehyde which could 188 
regenerate 4MV and decrease reduction to 4MP when Module 4 is added.  Both aldehyde 189 
dehydrogenases were used for alternate versions of the full pathway, and only the feaBEc strain (Strain 190 
M1F2P34) produced 4MP (67 ± 13 mg/L) while the puuCEc strain (Strain M1P2P34) produced 4MV (67 ± 191 
11 mg/L) (Supplementary Fig. S5B).   Additionally the puuCEc strain produced more butyrate (156 ± 4 192 
mg/L) and less butanol (15 ± 6 mg/L) than the feaBEc strain (62 ± 15 mg/L butyrate, 49 ± 17 mg/L 193 
butanol).   194 
While a demonstration of 4MP synthesis from glucose was made, relatively low 4MP titers and high 195 
isobutyrate (1113 ± 34 mg/L) and isobutanol (2205 ± 225 mg/L) titers suggested there were possible 196 
bottlenecks in the initial strain, Strain M1F2P34.    The ATP-dependent isobutyrate activator, ibuARp, was 197 
used in place of the CoA transferase pctMe in order to relieve acetyl-CoA requirements and create redox 198 
neutrality for the pathway.  New plasmid constructs were made to reorganize genes onto plasmids by 199 
module (Supplementary Table S2 and S4).  It was anticipated that operon construction would reduce 200 
enzyme expression, especially for genes in the second position, but it was unknown if the effect would 201 
be detrimental to overall production without knowledge of the rate limiting enzyme64.  Two Module 3 202 
plasmid variants were tested to explore whether PhaBRe activity could become limiting when expressed 203 
from an operon used in the new constructs (Supplementary Fig. S6A).  The variant with phaBRe in the 204 
first position of a two gene operon generated higher titers supporting the theory that phaBRe could be 205 
the limiting activity within Module 3.  Comparison of phaBCn expression from the two operon variants by 206 
SDS-PAGE confirmed higher phaBCn expression when placed in the first postion (Supplementary Fig. S6B).  207 
Additionally, operon variants for alsSBs and ilvCEc expression were tested to examine if better balancing 208 
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of flux between Module 1 and the native acetyl-CoA pathway could improve 4MP production 209 
(Supplementary Fig. S6A).  Placing alsSBs in the second position while using the new plasmid constructs 210 
(Strain M1F(IA)2I34) increased 4MP titers (168 ± 31 mg/L) while reducing isobutyrate (290 ± 24 mg/L) 211 
and isobutanol (1046 ± 45 mg/L) titers (See Supplementary Text for further details). 212 
Based on available in vitro data and the presence of 4MV (42 ± 7 mg/L) even for improved Strain 213 
M1F(IA)2I34, it was possible that FeaBEc could be oxidizing 4-methyl-valeraldehyde into 4MV creating a 214 
futile cycle with CarNi (Fig. 3A, Supplementary Fig. S6C).  An aldehyde dehydrogenase, Fjoh2967Fj from 215 
Flavobacterium johnsonaie had been found to prefer an isobutyraldehyde substrate over other aldehyde 216 
substrates when tested in vitro 46.  Replacing feaBEc with Fjoh2967Fj in Strain M1Fj(IA)2I34 led to 217 
increased 4MP (193 ± 23 mg/L, 0.033 ± 0.005 mol/mol glucose) and elimination of detectable 4MV (Fig. 218 
3B).  Isobutyrate titers (424 ± 9 mg/L, 0.084 ± 0.004 mol/mol glucose) were increased and isobutanol 219 
titers (797 ± 7 mg/L, 0.187 ± 0.006 mol/mol glucose) were reduced (Fig. 3C).   220 
In order to examine if alcohol toxicity could be limiting product titers, toxicities of the dominant 221 
byproduct isobutanol and desired product 4MP were assayed through exogenous addition of alcohols to 222 
the growth medium at concentrations from 1-10 mM.  Isobutanol and 4MP concentrations up to 5 mM 223 
did not inhibit the exponential growth rate (Supplementary Fig. S7).   A combination of 10 mM (741 224 
mg/L) isobutanol and 2 mM (204 mg/L) 4MP (comparable to titers observed for Strain M1Fj(IA)2I34) 225 
only reduced the exponential growth rate by 10%, the same reduction observed with 10 mM isobutanol 226 
alone.  While endogenously produced alcohols may be involved in alternative toxicity mechanisms, this 227 
result suggests that current titers are likely not limited by product toxicity. 228 
Achieving Pathway Selectivity through Enzyme Selection (Revisiting Module 4).  With knowledge of the 229 
specificity of CarNi for 4MV over isobutyrate, the continued high isobutanol titers suggested Adh6pSc was 230 
converting the isobutyraldehyde intermediate to isobutanol (Fig 4A).  Removing ADH6Sc from Strain 231 
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M1F(IA)2I34 produced Strain M1F(IA)2I34a which generated an isobutanol titer of 27 ± 3 mg/L with 232 
nearly undetectable butanol and 4MP titers (Fig. 4B).   An alternative to ADH6Sc was identified from 233 
Leifsonia sp. Strain S749.  The new alcohol dehydrogenase LsadhLs was hypothesized to have improved 234 
specificity for 4-methyl-valeraldehyde based on substrates that were assayed in vitro 58.  When lsadhLs 235 
was combined with the isobutyraldehyde specific dehydrogenase Fjoh2967Fj in Strain M1Fj(IA)2I34L, 236 
Selective synthesis of 4MP was achieved over other alcohol byproducts (Fig 4C).  Isobutanol titers were 237 
reduced to 21 ± 3 mg/L similar to those observed with the no alcohol dehydrogenase control.  4MP was 238 
produced at 90 ± 7 mg/L (0.016 ± 0.001 mol/mol glucose) making up 81% of all alcohol products.  The 239 
dominate byproducts were the 4MP precursors acetate (592 ± 34 mg/L, 0.177 ± 0.010 mol/mol glucose)  240 
and isobutyrate (1128 ± 34 mg/L, 0.229 ± 0.002 mol/mol glucose), suggesting that byproduct shunts 241 
were reduced and further improvement could be made by relieving a downstream rate limitation in 242 
Module 2, 3, or 4 (Supplementary Fig. S8).  While 4MP titers were lower with LsadhLs, SDS-PAGE analysis 243 
of LsadhLs confirmed strong overexpression in E. coli (Supplementary Fig. S8C).  The reduction in titer is 244 
likely due to the change from an NADPH-dependent dehydrogenase (Adh6pSc) to an NADH-dependent 245 
dehydrogenase (LsadhLs) under the aerobic conditions used.  The ratio of NADH/NAD
+ has been 246 
observed to be lower than that of NADPH/NAD+ under similar culture conditions65. 247 
Discussion 248 
Recent efforts to develop microbial pathways for chemical synthesis have moved beyond upregulation 249 
of native pathways to include transfer and modification of heterologous pathways to new hosts and 250 
modified termination of native host pathways.  Only a small number of truly de novo pathway designs 251 
have been published and most use isolated heterologous enzymes acting on their cognate substrates 18, 252 
19, 20, 51. Engineered pathways to liquid fuels, in particular, have predominantly relied on entirely natural 253 
(ethanol, butanol, isoprenoid) or terminally modified natural pathways (fatty acid synthesis, amino acid 254 
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αKAE, isoprenoid).  The presented work moves beyond modification of natural pathways by successfully 255 
demonstrating synthesis of a C6 branched alcohol via an extended de novo pathway which maintains 256 
selectivity while utilizing multiple naturally occurring enzymes outside their native pathway contexts.  257 
While one set of Modules has been presented in the current work, alternate chemistries could be 258 
substituted for or combined with the selected modules to create new pathways to the same or alternate 259 
products.  For example, an isobutyryl-CoA mutase or branched α-keto-acid decarboxylase route could be 260 
used to generate the isobutyryl-CoA precursor in place of Modules 1 and 2 66.  Similarly, a FAS route 261 
could be substituted for Module 3 to generate the longer saturated acid substrate for Module 467.  Using 262 
this design, individual alternative modules or module combinations can be directly compared to the 263 
existing pathway in vivo.  In addition, entirely new classes of branched products (e.g., aldehydes, 264 
alkanes) could be made by using different Module 4 enzymes.   265 
For the presented pathway, an iterative screening approach identified the enzymes catalyzing 266 
conversion of the downstream 4-methyl-valeraldehyde and upstream isobutyraldehyde intermediates 267 
as key components controlling selectivity of the pathway.  Our initial Module 4 alcohol dehydrogenase 268 
selection, Adh6pSc, proved to be highly active, but non-selective in the full pathway context.  Module 4 269 
displayed high activity on our desired substrate, but in vivo results with the full pathway suggested this 270 
module had a broad substrate range.    Persistent high isobutanol titers from strains expressing Modules 271 
1-4 suggested that Module 4 enzymes were interacting with isobutyrate and/or isobutyraldehyde.  In 272 
vitro and in vivo data from Module 4 testing implicated the alcohol dehydrogenase, Adh6pSc, as the non-273 
selective enzyme (Fig. 2 and 4). By replacing Adh6pSc with the isobutyraldehyde specific and NADH-274 
dependent alcohol dehydrogenase, LsadhLs, pathway selectivity and overall cofactor utilization were 275 
improved.   276 
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As with alcohol dehydrogenase candidates, we initially selected aldehyde dehydrogenases previously 277 
validated for an isobutyraldehyde substrate in an engineered pathway.  Two endogenous enzymes, 278 
PuuCEc and FeaBEc, were previously identified as the most effective E. coli aldehyde dehydrogenases for 279 
isobutyraldehyde oxidation to isobutyrate 45.  Of the two E. coli aldehyde dehydrogenases, FeaBEc 280 
proved to successfully synthesize 4MP from glucose in Strain M1F2P34 expressing Modules 1,2, 3, and 4 281 
(Fig. 3B).  Based on in vitro data one may predict PuuCEc to function more effectively because its kcat/Km 282 
is more consistent across substrate lengths while the kcat/Km of FeaBEc actually increases by an order of 283 
magnitude between propionaldehyde and hexanaldehyde substrates68, 69.  In vivo results disproved this 284 
prediction with only FeaBEc producing 4MP (Fig. 3A).  The better performance of FeaBEc in the context of 285 
the full pathway may be explained by reported Km values for the two dehydrogenases.  FeaBEc has Km 286 
values below 100 μM for relevant substrates while the Km values for PuuCEc are 1 mM.    PuuCEc and 287 
FeaBEc were tested in strains expressing ADH6Sc.  Like FeaBEc, Adh6pSc has reported Km values for relevant 288 
substrates in the 100-200 μM range54.  Adh6pSc was observed to have kcat values ( 100 sec-1) an order 289 
of magnitude higher than values observed for FeaBEc and PuuCEc ( 10 sec-1) for related aliphatic 290 
aldehydes.   Together these observed kinetics support the hypothesis that Adh6pSc out-competes PuuCEc 291 
and FeaBEc for the isobutyraldehyde substrate.  Isobutyraldehyde and reducing equivalents are diverted 292 
to isobutanol, lowering 4MP titers (Supplementary Fig. S5).  Strain M1P2P34 with PuuCEc produces 293 
significantly more isobutanol than Strain M1F2P34 with FeaBEc, as expected based on observed Km 294 
values.   295 
In addition, in vitro data suggested that even though FeaBEc functioned as an isobutyraldehyde 296 
dehydrogenase, it may also favor a 4-methyl-valeraldehyde substrate.   The potential futile cycle created 297 
by activity on 4-methyl-valeraldehyde was avoided by using the isobutyraldehyde specific 298 
dehydrogenase Fjoh2967Fj from Flavobacterium johnsonaie 
46.  Replacing feaBEc with Fjoh2967Fj led to 299 
increased isobutyrate and eliminated detectable 4MV production (Fig. 3).  Combining more selective 300 
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alcohol and aldehyde dehydrogenases led to a highly selective overall pathway with the major 301 
byproduct being overflow of the upstream intermediate isobutyrate (Supplementary Fig. S6).  Together 302 
the results from alcohol and aldehyde dehydrogenase selection highlight the importance of considering 303 
both high activity and required selectivity when utilizing retro-biosynthetic screening.  Proposing 304 
potential upstream pathways is required to identify intermediates which could have cross-reactivity 305 
with downstream enzymes. 306 
Further engineering of the CoA-dependent 4MP pathway is warranted given the potential high energy 307 
yield.   Dugar and Stephanopoulos have outlined the importance of balancing reducing equivalents 308 
generated and consumed in a recombinant pathway if high yields are desired 39.  Using the current 4MP 309 
pathway enzymes the overall reaction can be written as: 310 
1.5 C6H12O6 + 3 ADP + 3 NAD
+ + 3 NADPH 311 
 312 
C6H14O + 3 CO2 + 1 H2O + 2 AMP + Pi + 1 ATP + 3 NADH + 3 NADP
+ + 1 H+ 313 
The reducing equivalents of the pathway are balanced, but some are contained in different cofactors.  314 
The maximum pathway energy efficiency ( Pγ ) can be calculated using the degrees of reductance and 315 
pathway stoichiometry for a glucose substrate and 4MP product.  Maximum pathway energy efficiency 316 
for the αKAE pathway and the presented CoA-dependent pathway are 75% and 100%, respectively.  317 
Accounting for cofactor requirements, the adjusted pathway energy efficiencies ( ,P GCIη ) are 24% and 318 
45% for the αKAE and CoA pathways respectively (Supplementary Methods).  If alternative enzymes are 319 
identified or engineered to accept NADH in place of NADPH, maximum pathway yields could be achieved 320 
under anaerobic fermentation.  The maximum adjusted efficiency values for these pathway 321 
architectures then become 28% (αKAE) and 100% (CoA). The yield calculations highlight how our rational 322 
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design approach leads to a pathway architecture with high yield potential unlike inherently limited 323 
pathways utilizing modification of amino acid synthesis. 324 
This work has identified a novel pathway for the selective synthesis of the branched medium-chain 325 
length alcohol 4MP.  The highest titers (193 ± 23 mg/L) were achieved with Strain M1Fj(IA)2I34 which 326 
expresses both Fjoh2967Fj and ADH6Sc.  Selectivity was achieved by replacing ADH6Sc with lsadhLs in 327 
Strain M1Fj(IA)2I34L.  The 90 ± 7 mg/L of 4MP produced by M1Fj(IA)2I34L represented 81% of observed 328 
alcohol products.  In comparison, of the 9 alcohols generated in the previous demonstration of microbial 329 
4MP synthesis using α-KAE, 4MP (202.4 ± 1.1 mg/L) makes up 14% of the total alcohol product29. High 330 
potential efficiency and selectivity make our CoA pathway a preferred candidate for future engineering.  331 
Currently, the major byproducts of the CoA-dependent route are the acids acetate, isobutyrate, and 332 
butyrate (Fig. S8).  We expect that a combination of tuning thioesterase/transferase activities of the 333 
host to selectively cleave the longer 4-methyl-valeryl-CoA intermediate and relieving Module 3 rate 334 
limitations will further enhance titers.  Ultimately, screening or engineering for NADH-dependent 335 
enzymes should produce a high yielding fermentative pathway.  Our existing pathway can also be 336 
adapted to produce other branched medium-chain products by testing new downstream modules.  337 
Finally, we believe the pathway design approach described here can be useful for creation of new 338 
metabolic pathways which rely on long de novo routes.  Using retro-biosynthetic screening within a 339 
proposed pathway framework allows exploration of diversity using a small number of assays while 340 
constraining enzyme space to a chemical route which is maximally efficient for a given product.   341 
 342 
Methods 343 
Bacterial Strains and Plasmids:  E. coli MG1655(DE3) ΔendA ΔrecA described previously  was the host 344 
strain for production experiments, alcohol toxicity experiments and for protein expression analysis using 345 
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cell lysates70.  E. coli DH10B (Invitrogen, Carlsbad, CA) and ElectroTen-Blue (Stratagene, La Jolla, CA) 346 
were used in plasmid cloning transformations and for plasmid propagation.  E. coli BL21Star(DE3) (Life 347 
Technologies, Grand Island, NY) was used for expression of carNi for purification. (See Supplementary 348 
Tables S1 & S2 for strain details) 349 
A codon optimized version of S. cerevisiae ADH6 was purchased from DNA 2.0 (Menlo Park, CA) and 350 
codon optimized versions of N. iowensis car and B. subtilis sfp were purchased from GenScript 351 
(Piscataway, NJ) (See Supplementary Methods for codon optimized sequences).  T. denticola ter and E. 352 
gracilis ter were purchased from GenScript (Piscataway, NJ) as described previously 15. Leifsonia sp. 353 
Strain S749 lsadh was purchased as a codon optimized GeneArt String from Life Technologies (Grand 354 
Island, NY).   All other genes were amplified from gDNA.  B. subtilis PY79, E. coli MG1655, P. putida 355 
KT2440, C. necator (formerly R. eutropha) H16, M. elsdenii, R. palustris CGA009, P. syringae DC3000, C. 356 
acetobutylicum ATCC 824, and S. oneidensis MR-1 gDNA were prepared using the Wizard Genomic DNA 357 
purification Kit (Promega, Madison, WI).  P. aeruginosa PAO1-LAC (ATCC# 47085), F. johnsonaie (ATCC# 358 
17061) and V. parahaemolyticus EB 101 (ATCC# 17802) gDNA were purchased from American Type 359 
Culture Collection (Manassas, VA).  Custom oligonucleotide primers were purchased (Sigma-Genosys, St. 360 
Louis, MO) for PCR amplification of genes from gDNA using either Phusion High-Fidelity DNA polymerase 361 
(Finnzymes, Thermo Scientific Molecular Biology) or Q5 High-Fidelity DNA polymerase (New England 362 
Biolabs, Ipswich, MA).  Synthetic operons were constructed using a modified Splice by Overlap Extension 363 
(SOE) PCR method.    364 
The compatible vector set pETDuet-1, pCDFDuet-1, pACYCDuet-1, and pCOLADuet-1 was used to express 365 
single genes or synthetic operons under control of a T7lac promoter and individual ribosome binding 366 
sites.  Plasmids were constructed using standard molecular biology techniques with restriction enzymes 367 
and T4 DNA ligase purchased from New England Biolabs.  Ligation products in pETDuet-1, pACYCDuet-1, 368 
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and pCOLADuet-1 were used to transform E. coli DH10B and pCDFDuet-1 products were used to 369 
transform E. coli ElectroTen-Blue.  Propagated constructs were purified using a QIAprep Miniprep Kit 370 
(Qiagen, Valencia, CA) and agarose gel fragments were purified using a Zymoclean Gel DNA Recovery Kit 371 
(Zymo Research, Irvine, CA).  Completed constructs were used to co-transform E. coli MG1655(DE3) 372 
ΔendA ΔrecA. (See Supplemenatry Table S3 for plasmid details). 373 
Splice by Overlap Extension:  Initial PCR products with homologous ends were added to a PCR mixture 374 
without additional primers and cycled through a standard PCR cycle 4 times with annealing 375 
temperatures set at 6°C above, 3°C above, and at the designed melting temperature for the homology.  376 
The upstream primer for the upstream gene and the downstream primer for the downstream gene in 377 
the designed operon were then added to amplify the full length product.  A standard PCR method using 378 
the annealing temperature for the primer pair was used for final amplification. 379 
Culture Conditions:  For all production experiments triplicate seed cultures were grown from isolated 380 
colonies at 30°C overnight in 3 ml LB medium in a 14 ml culture tube on a rotary shaker at 250 rpm.  All 381 
production cultures were inoculated with 1% inoculum from overnight seed culture and grown at 30°C 382 
on a rotary shaker at 250 rpm.  Cultures were induced with 0.5 mM IPTG when OD600 values reached 0.6-383 
1.0 corresponding to mid-exponential phase.  For constructs designed for 4MV production 50 ml 384 
cultures in 250 ml shake flasks were used, and for constructs designed to produce 4MP 3 ml cultures in 1 385 
inch diameter 50 ml screw-cap culture tubes (Pyrex VISTA) were used. Unless otherwise stated, 1 ml 386 
culture samples were taken 48 hours post induction, centrifuged to pellet cells, and the supernatant was 387 
removed for analysis. 388 
For production of 4-methyl-valerate and 4-methyl-pentanol from glucose and isobutyrate, LB medium 389 
supplemented with 1% glucose and 10 mM isobutyrate was used.  For production of 4-methyl-valerate 390 
and 4-methyl-pentanol from glucose, LB medium supplemented with 1.2% glucose was used.  Samples 391 
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were taken 48 hours post induction except for initial experiments with Strains M1F2P34 and M1P2P34 392 
when samples were taken 72 hours post induction. 393 
For assessing toxicity of isobutanol and 4MP, an MG1655(DE3) ΔendA ΔrecA seed culture was grown 394 
overnight in LB medium.  Duplicate 3 ml cultures in LB + 1.2% glucose + alcohol were inoculated to an 395 
initial OD600 of 0.1.  Cultures were contained in the same 50 ml screw-cap tubes used in production 396 
experiments.  Cultures contained 1 mM isobutanol, 5 mM isobutanol, 10 mM isobutanol, 1 mM 4MP, 5 397 
mM 4MP, 10 mM 4MP, or no alcohol.  Growth was monitored by optical density and the growth rate 398 
was calculated from a linear regression of the natural log of the OD600 values for the 1.5, 2, and 2.5 hour 399 
post-inoculation time points. 400 
Relative Activity Assay for Purified his-Car: An overnight culture of BL21 Star (DE3) (Invitrogen) 401 
harboring pET/His-Car-RBS2-Sfp was used as 10% (v/v) inoculum in 2 L of LB Broth. The culture was 402 
incubated at 30°C and 250 rpm, and expression was induced using a final concentration of 1 mM IPTG at 403 
OD 0.6. Cells were harvested after 20 hours using centrifugation and resuspended in a buffer containing 404 
50 mM Tris-HCl pH 8.0, 300 mM NaCl, and 10% glycerol. Cells were subsequently lysed using sonication. 405 
The supernatant was collected and applied to a column containing Ni-NTA resin (Qiagen).  Affinity 406 
chromatography was performed using step-wise increasing concentrations of imidazole. Fractions 407 
containing purified His6-Car were dialyzed overnight at 4°C into 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 408 
mM DTT, and 10% glycerol. Dialyzed enzyme was then flash frozen using liquid nitrogen and stored at -409 
80°C. 410 
The activity of His-Car on various substrates was determined by measuring changes in absorbance at 340 411 
nm for up to 5 minutes in 96-well microplates (Tecan Infinite F200 Pro). Reactions were prepared as 412 
follows: 100 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.6 mM NADPH, 1 mM ATP, 224 nM His-Car, and 50 mM 413 
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pH neutralized acid substrate. All substrates were assayed in triplicate. For KMand Vmax determinations, 414 
substrates were assayed at 5 different concentrations. 415 
SDS-PAGE Analysis:  E. coli MG1655(DE3) ΔendA ΔrecA  was transformed with empty pETDuet-1, pET-416 
(bktBCn-terTd)-(phaBCn-phaJ4bCn), pET-(bktBCn-terTd)-(phaJ4bCn-phaBCn) pACYC-(carNi-sfpBs)-ADH6Sc, or 417 
pACYC-(carNi-sfpBs)-lsadhLs.  Single colonies from plates of each transformation were grown overnight in 418 
3 ml of LB with appropriate antibiotic.  Shake flask cultures (250 ml flasks) containing 50 ml LB + 0.6% 419 
glucose were inoculated at 1% inoculum from overnight LB cultures and incubated with agitation at 30°C 420 
and 250 rpm.  Shake flasks were induced with 0.5 mM IPTG OD600 values between 0.5 and 0.6.   421 
Five and a half hours after induction 7 ml of each culture were sampled and pelleted by centrifugation.  422 
Cell pellets were resuspended in 1 ml of 10 mM Tris-HCl at pH 8.0 and added to 1.7 ml microcentrifuge 423 
tubes containing 500 ul of 0.1 mm diameter glass beads (Scientific Industries, Inc. Disruptor Beads, SI-424 
BG01).  Samples were then vortexed for 10 minutes.   425 
After lysis, samples were pelleted by centrifugation (6,000g, 4°C, 10 min) and the supernatant was 426 
removed as soluble lysate.  Total protein was quantified by a previously described Bradford assay 427 
method using Bio-Rad Protein Assay Dye Reagent (Cat #500-0006)71.  A Bio-Rad 10% Mini-PROTEAN TGX 428 
gel (Cat #456-1034) was run using the Mini-PROTEAN Tetra Cell electrophoresis set up.  Bio-Rad 429 
Precision Plus Protein All Blue Standard (Cat #161-0373) and 10 μg of total protein for each sample was 430 
loaded on the gel.  After running at 200 volts for 33 minutes, the gel was washed with deionized water 431 
before staining with Bio-Rad Bio-Safe Coomassie Stain (Cat #161-0786). 432 
Metabolite Analysis:  Culture samples were pelleted by centrifugation and supernatant was removed 433 
for HPLC analysis with an Agilent 1200 series instrument with a refractive index detector.  Analytes were 434 
separated using the Aminex HPX-87H anion exchange column (Bio-Rad Laboratories, Hercules, CA) with 435 
a 5mM sulfuric acid mobile phase at 35°C and a flowrate of 0.6 ml/min.  Commercial standards of 436 
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glucose, α-ketoisovalerate, acetate, acetoin, isobutyrate, butyrate, isobutanol, butanol, 4-methyl-437 
valerate, and 4-methyl-pentanol were used for quantification of experimental samples by linear 438 
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Table 1:  Strains Used for Module and Full Pathway Evaluation.  Host strains and plasmids are listed.  Strain names 
indicate the modules present in the strain, i.e. M1F2P34 includes “M” for modules, “1F” for Module 1 with feaBEc, 
“2P” for Module 2 with pctMe, “3” for Module 3 and “4” for Module 4.  Strains with “( )” contain abbreviations for 
operon structure indicating the order of alsSBs and ilvCEc, i.e. M1F(IA)2I34 indicates that it contains an ilvCEc-alsSBs 
operon. Key strains indicated in bold. 
Figures: 
Figure 1:  4-methyl-pentanol (4MP) pathway schematic and alternative biofuel pathways. (A) The α-ketoacid 
elongation (αKAE) pathway was previously used to synthesize 4MP among other products.  The αKAE route utilizes 
relatively inefficient single-carbon extension and non-specific decarboxylation and reduction of upstream 
precursors resulting in a redox imbalance and a mix of products, three of which are shown. (B) Thepresented CoA-
dependent  pathway to 4MP is assembled with genes from 9 organisms taken from 10 different pathway contexts.  
Pathway genes are shown with known native pathways or putative metabolic roles.  Selectivity for 4MP was 
achieved while requiring enzymes for Modules 3 and 4 to act on noncognate substrates. (C) The 4MP pathway can 
be organized into 4 modules which were used to identify better performing enzymes for individual steps and 
validate portions of the overall pathway independently in vivo: Module 1, modified valine biosynthesis to 
isobutyrate; Module 2, isobutyrate activation to isobutyryl-CoA; Module 3, CoA-dependent condensation and 
reduction of isobutyryl-CoA and acetyl-CoA to 4-methyl-valerate (4MV); Module 4, reduction of 4MV to 4MP.  
Genes in italics were overexpressed from plasmid sets.  Modules were constructed working backwards from the 
4MP product.  A potential byproduct shunt to butyrate and butanol was monitored during pathway construction.  
Figure 2:  Tuning of pathway selectivity by the carboxylic acid reductase CarNi.  (A)  In vitro analysis of his-purified 
CarNi reveals a dependence on acid primary-chain length with maximum activity at a chain length of five and six 
carbons.  Branching at the C4 position is preferred significantly over straight acid species.  The potential substrates 
for byproduct formation, butyrate and isobutyrate, are seen to have 56% and 25% of the observed activity on 4-
methyl-valerate (4MV) respectively.  (B)  Michaelis-Menten kinetics for isobutyrate and 4MV reveal that CarNi has a 
strong preference for the latter intermediate.  (C) CarNi substrate preference influences product selectivity in vivo 
generating 1.9 times as much 4-methyl-pentanol (4MP) (272 mg/L, 2.7 mM) as butanol (142 mg/L, 1.9 mM) in 
Strain M2P34 (expressing Module 2(pct), 3, and 4 genes) supplied with both glucose and isobutyrate.  Even though 
10 mM isobutyrate is supplied to the cultures of Strain M2P34 only 111 mg/L (1.5 mM) isobutanol is observed.  All 
data are presented as the mean ± s.d. (n=3) with in vivo data generated using biological triplicates. 
Figure 3:  4MP synthesis from glucose improved through aldehyde dehydrogenase selection.  (A) Key reactions 
involving aldehydes can generate futile cycles (aldehyde dehydrogenase feaBEc with the carboxylic acid reductase 
carNi) or byproduct shunts (alcohol dehydrogenase ADH6Sc).  The desired pathway route is shown in bold arrows 
within the shaded box.  Undesired reactions are shown with dashed arrows.  Enzymes with insufficient selectivity 
have dashed outlines.  (B) When feaBEc (Strain M1F(IA)2I34) was replaced with the isobutyraldehyde specific 
aldehyde dehydrogenase Fjoh2967Fj in Strain M1Fj(IA)2I34 4MV titers were reduced and 4MP titers were 
increased.  (C) Complementarily, Strain M1Fj(IA)2I34 (Fjoh2967Fj) produced lower isobutanol and higher 




Figure 4: Improved alcohol dehydrogenase selectivity with lsadhLs.  (A) The desired pathway reactions to 4MP are 
indicated by bold arrows with the byproduct shunt to isobutanol indicated by the dashed arrow.  High activity of 
Adh6pSc on isobutyraldehyde diverts isobutyrate flux to isobutanol.  The LsadhLs alcohol dehydrogenase’s 
selectivity for 4-methyl-valeraldehyde greatly reduces flux to the isobutanol shunt. (B) The alcohol profile of Strain 
M1F(IA)2I34 expressing feaBEc and ADH6Sc contains 168 ± 31 mg/L  of 4MP but is dominated by 1.046 ± 45 g/L of 
isobutanol.  The M1F(IA)2I34a control without ADH6Sc expression produces low to undetectable levels of all three 
alcohols.  (C) Replacing feaBEc with Fjoh2967Fj in Strain M1Fj(IA)2I34 reduces isobutanol (797 ± 20 mg/L) and 
increases 4MP (192 ± 23 mg/L) marginally.  Replacing ADH6Sc with lsadhLs greatly enhanced alcohol selectivity 






















































































































































































































































1.4 ± 0.1 78 ± 9 0.018 ± 0.002 

































































































































































Plasmid 3 Plasmid 4 Strain namePlasmid 1 Plasmid 2
pCOLA-kivDLl
-Fjoh_2967Fj
M1Fj(IA)2I34pACYC-(carNi-sfpBs)-ADH6Sc
pACYC-(carNi-sfpBs)
-lsadhLs
M1Fj(IA)2I34L
M2P3a
M2P3b
pCDF-pctMe
pET-(bktBCn-terTd)
-(phaJ4bCn-phaBCn)
pET-(bktBCn-terTd)
-(phaBCn-phaJ4bCn)
-
-
-
-
- -
Table-1 (Prather)
